» Authors » A Cruchley

A Cruchley

Explore the profile of A Cruchley including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 253
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Teh M, Tilakaratne W, Chaplin T, Young B, Ariyawardana A, Pitiyage G, et al.
J Oral Pathol Med . 2008 Feb; 37(7):430-6. PMID: 18284545
Background: Oral submucous fibrosis (OSF) is a high-risk pre-cancerous condition where 7-13% of these patients develop head and neck squamous cell carcinoma (HNSCC). To date there is no cancer predictive...
2.
Tilakaratne W, Iqbal Z, Teh M, Ariyawardana A, Pitiyage G, Cruchley A, et al.
J Oral Pathol Med . 2008 Jan; 37(6):372-7. PMID: 18221327
Background: Oral submucous fibrosis (OSF) is a precancerous condition showing extensive fibrosis of the submucosa and affects most parts of the oral cavity, including pharynx and upper third of the...
3.
Chidgey M, Brakebusch C, Gustafsson E, Cruchley A, Hail C, Kirk S, et al.
J Cell Biol . 2001 Nov; 155(5):821-32. PMID: 11714727
The desmosomal cadherin desmocollin (Dsc)1 is expressed in upper epidermis where strong adhesion is required. To investigate its role in vivo, we have genetically engineered mice with a targeted disruption...
4.
Patel M, Pavlovic P, Hughes F, King G, Cruchley A, Braden M
Biomaterials . 2001 Jul; 22(15):2081-6. PMID: 11432587
The release of recombinant human bone morphogenetic protein-2 (rhBMP-2) from three room temperature polymerising methacrylate systems has been studied. These all contained poly(ethyl methacrylate) powder, but the monomer liquids comprised,...
5.
Cicala C, Pinto A, Bucci M, Sorrentino R, Walker B, Harriot P, et al.
Circulation . 1999 May; 99(19):2590-7. PMID: 10330393
Background: The protease-activated receptor-2 (PAR-2) is expressed by vascular endothelial cells and upregulated by lipopolysaccharide (LPS) in vitro. PAR-2 is activated by a tethered ligand created after proteolytic cleavage by...
6.
Booth V, Young S, Cruchley A, TAICHMAN N, Paleolog E
J Periodontal Res . 1999 Jan; 33(8):491-9. PMID: 9879523
Vascular endothelial growth factor (VEGF) is a multifunctional angiogenic cytokine of importance in inflammation and wound healing but its presence in chronic inflammatory periodontal disease has never been reported. The...
7.
Murray P, Niedobitek G, Kremmer E, Grasser F, Reynolds G, Cruchley A, et al.
J Pathol . 1996 Jan; 178(1):44-7. PMID: 8778314
A new monoclonal antibody has been used to examine immunohistochemically the expression of the Epstein-Barr virus (EBV)-encoded nuclear antigen (EBNA) 1 in virus-associated epithelial lesions. EBNA1 was detected in the...
8.
Tenorio D, Cruchley A, Hughes F
J Periodontal Res . 1993 Nov; 28(6 Pt 1):411-9. PMID: 8254458
Recent studies have suggested that cementoblasts may be derived from osteoblast progenitor cells, although the cementoblast phenotype has not been extensively characterized. This immunocytochemical study was carried out to investigate...
9.
Speight P, Cruchley A, Williams D
J Oral Pathol Med . 1990 Mar; 19(3):126-30. PMID: 2187976
Plasma cells expressing IgG, IgA and IgM were quantified in labial salivary glands from patients with Sjögren's syndrome (SS) and compared with glands showing non-specific inflammatory changes and normal controls....
10.
Lesch C, Squier C, Cruchley A, Williams D, Speight P
J Dent Res . 1989 Sep; 68(9):1345-9. PMID: 2476469
Specimens from four regions of oral mucosa (palate, buccal mucosa, lateral border of the tongue, and the floor of the mouth) and of abdominal skin were taken from 58 individuals...